|
Strange Thing
In 2018, Eleven Biotherapeutics changed their name to Sesen Bio. It’s easy to discover that fact by scanning our list of defunct companies. But there must be something with the number 11, because in spite of this history, a new group has taken the name Eleven Therapeutics.
Hopefully they’ll go by Elle Therapeutics for short.
Overexuberant PR
Three people spit in a cup and the press release merited a title with an exclamation point. Don’t get us wrong, a saliva test that was as reliable as the brain-swab Covid test we’ve been stuck with to date would be great, but does anyone really get exclamation point-excited about Covid testing breakthroughs anymore?
Team Diversity
Always refreshing to see a picture of a lab group that tells you they care about diversity. A2Bio shows this with their 14-person lab group featuring Asian women, black women, white women, women with glasses, women with long hair, women with gloves, women without gloves, shorter women, taller women, older women & younger women. Diversity!
Find Therapeutics
This company doesn’t need to publish a mission statement – their name basically doubles as one. If their whole operation is this optimized, good things are ahead.
Team Roast – Zoom Edition
Have we not tortured our employees enough these past two years with all this Zoom nonsense? Do we really need to immortalize them by using Zoom screenshots on the Team page? NO ONE looks good on Zoom. Shame on you, Aarvik!
Stick to Crypto
Biotech is a fiendishly difficult place for outsiders to penetrate and succeed without extensive training. So when we hear of a 23 year-old with a Bachelors degree and industry experience consisting of an internship founding a company and getting $13M in investor cash, it sounds outlandish. But that’s the real story in Paris where Alexander Reeber has corralled that funding for his plant-based biomanufacturing company, Core Biogenesis. Would probably make more sense to refer to this source of funds as donors rather than investors. But who knows anymore - someone may acquire them for $100M before they ever create a product. #notmymoney
|